Communiqués de presse Newsfile Corp (Canada) — Biotechnology Santé & sciences de la vie — Flux RSS et veille en direct
PPN World suit le flux RSS de Newsfile Corp (Canada) — Biotechnology en temps réel — 52 communiqués indexés au cours des 30 derniers jours (environ 1,7 par jour), le plus récent est arrivé il y a 3 j. Suivez-le avec alertes sur recherches enregistrées, résumés IA et recherche plein texte, ou branchez l'URL RSS ci-dessous dans votre propre lecteur.
À propos de ce fil
Newsfile Corp (Canada) — Biotechnology fait partie des 1,400+ fils de presse que PPN World surveille en continu — un fil en anglais axé sur le secteur Santé & sciences de la vie, classé sous « Canada » dans notre index par pays. Chaque communiqué est dédupliqué, géolocalisé et enrichi d'un résumé IA, et vous pouvez y attacher des alertes sur recherches enregistrées. Au cours des 30 derniers jours, Newsfile Corp (Canada) — Biotechnology a publié 52 communiqués — environ 1,7 par jour, surtout le mardi.
Suivez Newsfile Corp (Canada) — Biotechnology en temps réel dans PPN World
Chaque communiqué de Newsfile Corp (Canada) — Biotechnology arrive dans le cockpit quelques secondes après sa publication — dédupliqué, classé, avec alertes sur recherches enregistrées et résumés IA, aux côtés de 1,400+ autres fils. Essai gratuit de 72 h, sans carte.
Commencer l'essai gratuit →Derniers communiqués de Newsfile Corp (Canada) — Biotechnology
- MustGrow Receives First Milestone Payment from Bayer AGil y a 2 j
Bayer AG has paid MustGrow the first development milestone payment. The MustGrow / Bayer AG License and Collaboration Agreement, signed in December 2023, covers soil applications of MustGrow's mustard…
- Noveris Health Sciences Announces Proposed Private Placement of Convertible Debentures for up to $500,000il y a 3 j
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") is pleased to announce its intenti…
- iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeksil y a 3 j
Woburn, Massachusetts--(Newsfile Corp. - August 20, 2026) - iSpecimen, (NASDAQ: ISPC) a provider of human biospecimens, recently completed an international cancer research project involving hundreds o…
- Hemostemix Commercializes Its Vascular Dementia Clinical Trial of VesCell(TM) Under LARTAil y a 3 j
Leading cognitive-disorders specialist, Dr. William Shankle, will discuss vascular cognitive impairment, vascular dementia and the proposed clinical trial of VesCell™ (ACP-01) today at 12:00 EST, at h…
- Maxwell Biosciences' Spinout SHU.ai Announces Closing of $1M Financing Roundil y a 3 j
Austin, Texas--(Newsfile Corp. - August 20, 2026) - Maxwell Biosciences, a global health technology company pioneering a new category of immune-inspired small molecules called Claromers®, December 5,…
- TempraMed Announces Extension of Maccabi Healthcare Services Agreementil y a 3 j
Toronto, Ontario--(Newsfile Corp. - August 20, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (OTCQB: TMPTF) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology innovator focused on tempe…
- TempraMed Announces Extension of Maccabi Healthcare Services Agreementil y a 3 j
Toronto, Ontario--(Newsfile Corp. - August 20, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (OTCQB: TMPTF) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology innovator focused on tempe…
- Marvel Biosciences Expands Private Placement to Quebecil y a 4 j
Calgary, Alberta--(Newsfile Corp. - August 19, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) ("Marvel" or the "Company") announces that it is expanding its previously announced private…
- Marvel Biosciences Expands Private Placement to Quebecil y a 4 j
Calgary, Alberta--(Newsfile Corp. - August 19, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) ("Marvel" or the "Company") announces that it is expanding its previously announced private…
- Illumisoft Appoints Ehsan Agahi as CEO, Commences Trading on OTCQB Venture Market, Announces Shares for Debt Settlementil y a 4 j
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - Illumisoft Lighting Corp. (TSXV: UVC) (OTCQB: FUVCF) ("Illumisoft" or the "Company") today announced that Ehsan Agahi, currently Execu…
- Illumisoft Appoints Ehsan Agahi as CEO, Commences Trading on OTCQB Venture Market, Announces Shares for Debt Settlementil y a 4 j
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - Illumisoft Lighting Corp. (TSXV: UVC) (OTCQB: FUVCF) ("Illumisoft" or the "Company") today announced that Ehsan Agahi, currently Execu…
- Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporationil y a 4 j
Encinitas, California--(Newsfile Corp. - August 19, 2026) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora") today announced that it has licensed the development and commercialization rights for K…
Les plus récents communiqués de ce fil défilent en direct pour les membres PPN World.
Questions fréquentes
Comment suivre les communiqués de Newsfile Corp (Canada) — Biotechnology en temps réel?+
À quelle fréquence les communiqués de Newsfile Corp (Canada) — Biotechnology sont-ils relevés?+
Quel type de communiqués Newsfile Corp (Canada) — Biotechnology publie-t-il?+
Fils liés
- Newsfile Corp (Canada) — All Releases
- Newsfile Corp (Canada) — Mining & Metals
- Newsfile Corp (Canada) — Cannabis
- Newsfile Corp (Canada) — Technology
- Newsfile Corp (Canada) — Energy
- Newsfile Corp (Canada) — Aerospace & Defence
- Newsfile Corp (Canada) — Fil français
- Statistics Canada — The Daily: Health
- PR Newswire (Canada) — All Releases
- PR Newswire (Canada) — Financial Services